Core Insights - The article highlights the rapid development of Hong Kong's biotechnology industry, driven by collaboration with mainland China and innovative companies like Yuanhua Intelligent Technology and China Antibody Pharmaceutical Company [1][5][6] Company Summaries - Yuanhua Intelligent Technology, founded in 2018, specializes in high-end intelligent medical equipment and has successfully completed over 5,000 surgeries using its surgical robots [3][5] - China Antibody Pharmaceutical Company focuses on antibody drug development and has established strategic partnerships to enhance its research capabilities and expedite the commercialization of its products [5][6] Industry Trends - The number of biotechnology-related companies in Hong Kong has increased from 2,340 in 2013 to 3,020 in 2023, marking a nearly 30% growth [6] - The Hong Kong government is fostering an environment conducive to biotechnology innovation through supportive policies, funding channels, and talent attraction [6]